The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

but drug companies and some obesity specialists have expressed concerns that some compounded products aren’t FDA-approved. After the suit was filed, the FDA temporarily paused to reconsider the ...

An Post has issued two new stamps celebrating Irish women in the fields of science, technology, engineering and maths to mark International Women’s Day. This honour was awarded to two women with ...

Copyright 2025 The Associated Press. All Rights Reserved. This Thursday, Feb. 11, 2016, file photo shows the Cadillac logo, a General Motors Co. brand, on display on ...

If you're ever unsure of something, speak with your doctor. FDA drug development and approval allows a proposed remedy to be tested to determine its safety and effectiveness. "FDA-approved ...

MedRhythms, a Portland-based digital health startup founded in 2013, has won approval from the U.S. Food ... with McCarthy as president. With the FDA’s green light, MedRythms aims to introduce ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Thanks to Bella Hadid, we’ve found an everyday tote that’s both chic and quite practical.

See today's pick now. This marked the first approval of a new class of pain medication in more than 20 years, offering an alternative to traditional opioid treatments. According to the Formulary ...

Compounded drugs are sold at vastly lower prices than the branded versions, but drug companies and some obesity specialists have expressed concerns that some compounded products aren’t FDA-approved.